Gastrotech signs licensing agreement with Eli Lilly following positive clinical data on compound for Irritable Bowel Syndrome
30-Jan-2008 -
Gastrotech Pharma, a biopharmaceutical R&D company with a focus on the medical applications of gastrointestinal hormones, has signed an agreement with Eli Lilly and Company (Indianapolis, USA) to in-license a Lilly compound (now named GTP-010), an analogue of the naturally occurring intestinal ...
dyspepsia
Eli Lilly
hormones
+3